NRXS NeurAxis, Inc.
USHealthcareAs of 2026-07-10 14:38
Why NRXS matters now
NeurAxis, Inc. (NRXS) is a US stock in Healthcare. The latest InvestLog snapshot shows $7.15 with -0.90% on the session and $88.5M in market capitalization; recent performance reads 1-month -1.38% and YTD +57.49%.
The latest financial table shown here is Q1 2026, with revenue of $1.6M, net income of $-1.8M, and EPS of $-0.18. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -6.9%.
The latest indexable market news headline is "NeurAxis, Inc. (NRXS) Q1 2026 Earnings Call Transcript" from Seeking Alpha.
Additional event context on this page matters because analyst consensus is Buy with a median target of $8.00; recent insider activity includes Aharon Gil filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
13.62
P/S
20.68
EV/EBITDA
-11.50
DCF Value
$-5.05
FCF Yield
-6.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
85.0%
Operating Margin
-169.9%
Net Margin
-170.1%
ROE
-185.7%
ROA
-83.3%
ROIC
-119.2%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $1.6M | $-1.8M | $-0.18 |
| Q4 2025 | $968.1K | $-1.7M | $-0.16 |
| FY 2025 | $3.6M | $-7.8M | $-0.95 |
| Q3 2025 | $811.4K | $-2.1M | $-0.24 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$8.00
Target (Median)
$8.00
Target Range
$8.00 - $8.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
1.41
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.